Timing, hosts and locations of (grouped) events of NanoImpactNet

NANOMMUNE
Comprehensive Assessment of Hazardous
Effects of Engineered Nanomaterials on
the Immune System
NanoSafetyCluster - Compendium 2012
Contract Agreement: NMP4-SL-2008-214281 Website: http://www.nanommune.eu
Coordinator: Prof. Bengt Fadeel, Karolinska Institutet, Stockholm, Sweden
No. Beneficiary name Short name Country
1 Karolinska Institutet KI Sweden
2 Royal Institute of Technology KTH Sweden
3 Uppsala University UU Sweden
4 University of Cologne UC Germany
5 University of Turku UT Finland
6 Swiss Federal Laboratories for Materials Testing and Research EMPA Switzerland
7 Institute of Occupational Medicine IOM United Kingdom
8 University of Pittsburgh UP United States
9 National Institute for Occupational Safety and Health NIOSH United States
10 North Carolina State University NCS United States
Contents
1 Summary ................................................................................... 150
2 Overview of project .................................................................. 150
2.1 Introduction, scientific/industry needs, problem addressed150
2.2 Scope, objectives .................................................................... 151
2.3 Technical approach, work description .................................. 152
2.3.1 Synthesis and characterization of nanomaterials ........... 152
2.3.2 In vitro effects of nanomaterials: focus on immunecompetent
cells ................................................................ 152
2.3.3 In vivo effects of nanomaterials: focus on immune
responses.......................................................................... 153
2.3.4 Novel biomarkers of nanomaterial exposure: genomics
and lipidomics ................................................................... 153
2.3.5 Risk assessment of nanomaterials: steps towards safe
management .................................................................... 153
2.4 Important achievements ....................................................... 154
2.4.1 Interaction of carbon nanotubes with immunecompetent
cells ............................................................... 154
2.4.2 Gene expression profiling of nanoparticle-exposed
cells and tissues ............................................................... 154
2.4.3 Mapping the surface adsorption forces of
nanomaterials .................................................................. 155
2.5 Conclusions ............................................................................ 155
2.6 Dissemination of results ........................................................ 155
2.7 Nanosafety Cluster activities ................................................. 155
2.8 Selected publications ............................................................ 155
3 Directory.................................................................................... 156
4 Copyright ....................................................................................157
Compendium of Projects in the European NanoSafety Cluster 149